Actavis Reports Lower Profits as Acquisition Takes Toll
U.S. generics firm Actavis Inc (NYSE:ACT), previously Watson Pharmaceuticals, reported a strong jump in its revenues in the fourth quarter … Read more
U.S. generics firm Actavis Inc (NYSE:ACT), previously Watson Pharmaceuticals, reported a strong jump in its revenues in the fourth quarter … Read more
Nokia Corporation (ADR) (NYSE:NOK) (BIT:NOK1V) (HEL:NOK1V)’s inclination to spend cash faster than any of its competitors is worrying its bondholders … Read more
Mohnish Pabrai conducted an interview with DNAIndia.com which I just found this week thanks to Gurufocus. Mohnish Pabrai manages about … Read more